Persistent Shadows: Depression, Long COVID, and the Future of Mental Health Care

November 13, 2025 | John Murphy | Leave a Comment

Persistent Shadows: Depression, Long COVID, and the Future of Mental Health Care

Author: John Murphy Affiliation: COVID-19 Long-haul Foundation Abstract Long COVID has emerged as a multifaceted syndrome with profound neuropsychiatric consequences. Among its most persistent and disabling sequelae is depression, which…[...]

September 4, 2025 | John Murphy | Leave a Comment

Endothelial Disruption in Long COVID: Unraveling the Vascular Legacy of SARS-CoV-2

John Murphy, The COVID 19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a chronic multisystem disorder affecting millions worldwide. Among its most…[...]

August 8, 2025 | John Murphy | Leave a Comment

COVID-19 coagulopathy, thrombosis, and bleeding

Noel C. Chan, Jeffrey I. Weitz, Blood (2020) 136 (4): 381–383.https://doi.org/10.1182/blood.2020007335 In this issue of Blood, Al-Samkari et al expand our understanding of thrombosis and bleeding risks and their predictors in hospitalized patients with…[...]

July 23, 2025 | John Murphy | Leave a Comment

Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes

Viet Tran Le • Quoc Hung Ha • Minh Triet Tran • Ngoc Trong Le • et. al., DOI: 10.7759/cureus.27611 Abstract Background: Hyperglycemia is commonly seen in critically ill patients. This disorder was also seen in coronavirus disease 2019…[...]

July 15, 2025 | John Murphy | Leave a Comment

Sudden Sleep Collapse: A Long-COVID Nightmare

Long COVID can trigger sudden collapses in consciousness or overwhelming sleepiness through a mix of neurological, immunological, and autonomic dysfunctions. Here's how the body gets hijacked into shutdown mode: 🧠…[...]

June 25, 2025 | John Murphy | Leave a Comment

Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736 Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]

June 14, 2025 | John Murphy | Leave a Comment

Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amira Mohamed Taha • Amr Elrosasy • Ahmed S. Mohamed •et.al. DOI: 10.7759/cureus.70613 Abstract The international healthcare community has encountered several difficulties because of the COVID-19 pandemic brought on by SARS-CoV-2. COVID-19 can lead to an…[...]

April 19, 2025 | John Murphy | Leave a Comment

A Pilot Case-Control Study of Muscle and Bone Health Status in Patients Who Have Recovered From COVID-19 Infection

Shital Bhor • Dipali Ladkat • Nikhil Shah • Ketan Gondhalekar • Piyush Chaudhari • Anuradha Khadilkar, DOI: 10.7759/cureus.76283 Abstract Background: Coronavirus disease 2019 (COVID-19), resulting from the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects various bodily systems, including…[...]

April 8, 2025 | John Murphy | Leave a Comment

Long-Term Neurologic Complications of COVID-19: A Practical Overview

The authors present an overview of the presentation and management of common neurologic symptoms associated with long COVID. Anastasia Vishnevetsky, MD, MPH; Douglas R. Wilcox, MD, PhD; et. al. Practical…[...]

March 21, 2025 | John Murphy | Leave a Comment

Liver Enzymes and Inflammatory Markers Among Severely Ill COVID-19 Patients: A Retrospective Case-Control Study in Telangana

Pavuluri P, Menon M, Tummalacharla S, et al. (December 04, 2024) Liver Enzymes and Inflammatory Markers Among Severely Ill COVID-19 Patients: A Retrospective Case-Control Study in Telangana. Cureus 16(12): e75120.…[...]